Latham & Watkins advises Heramba in its acquisition of Kiepe Electric. Kiepe Electric, a company focused on the electrification of road and rail urban transportation applications, has...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising J.H. Whitney Capital Partners and Alphia, Inc., and Weil, Gotshal & Manges LLP is advising PAI Partners on the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises ArcLight in acquisition of minority interest in Kleen Energy Systems Power Plant. ArcLight Capital Partners, LLC has entered into a definitive purchase...
You must be a Standard 1 Year member to access this content.
Paul, Weiss advised the initial purchasers on the offering. Columbia Pipelines Operating Company LLC announced the offering of $4.6 billion aggregate principal amount of notes and...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Angeles Equity Partners LLC in the deal. Angeles Equity Partners LLC announced the final closing of Angeles Equity Partners II, L.P. and its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Hess Midstream in secondary public offering. Hess Midstream LP (NYSE: HESM) (HESM) has announced the pricing of an underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis is serving as legal counsel to Bain Capital, and Sullivan & Cromwell is serving as legal counsel to Fogo de Chão and Rhône...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises MindMed in growth financing with K2 HealthVentures. Mind Medicine Inc. (MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat...
You must be a Standard 1 Year member to access this content.
JunHe advised Antengene on the deal. Antengene Corporation Limited and Hansoh Pharmaceutical Group Company Limited jointly announced an agreement to collaborate on the commercialization of XPOVIO® and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises on Heron Therapeutics’ working capital credit facility. Heron Therapeutics, Inc. (Heron), a commercial-stage biotechnology company focused on improving the lives of patients...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises on Light & Wonder’s Private Offering of US$550 Million of Senior Unsecured Notes. Light & Wonder, Inc. (NASDAQ and ASX: LNW) has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised StepStone Real Estate on the deal. StepStone Real Estate, the real estate arm of New York-based private markets investment firm StepStone Group,...
You must be a Standard 1 Year member to access this content.
